Inferior petrosal sinus sampling in healthy human subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion

被引:49
作者
Kalogeras, KT
Nieman, LK
Friedman, TC
Doppman, JL
Cutler, GB
Chrousos, GP
Wilder, RL
Gold, PW
Yanovski, JA
机构
[1] NIMH, CLIN NEUROENDOCRINOL BRANCH, BETHESDA, MD 20892 USA
[2] NICHHD, DEV ENDOCRINOL BRANCH, BETHESDA, MD 20892 USA
[3] NIAMSD, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA
[4] NIAMSD, WARREN GRANT MAGNUSON CLIN CTR, OFF DIRECTOR, BETHESDA, MD 20892 USA
[5] NIAMSD, ARTHRIT & RHEUMATISM BRANCH, BETHESDA, MD 20892 USA
[6] UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, SCH MED, DEPT MED, LOS ANGELES, CA 90048 USA
关键词
hypothalamus; median eminence; adenohypophysis; neurohypophysis; oxytocin;
D O I
10.1172/JCI118640
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Arginine vasopressin (AVP) acts synergistically with corticotropin-releasing hormone (CRH) to stimulate ACTH release from the anterior pituitary, In a previous study of bilateral simultaneous inferior petrosal sinus (IFS) sampling in healthy human subjects, we observed lateralized ACTH secretion, suggesting lateralized secretion of an ACTH-regulating hypothalamic factor, To investigate this possibility, we measured ACTH, CRH, AVP, and oxytocin (OT) levels in the IFS and the peripheral circulation in nine normal volunteers, before and after 1 mu g/kg i.v. bolus ovine CRH (oCRH). At baseline, ACTH, AVP, and OT exhibited a significant (P < 0.05) two to threefold intersinus gradient (ISG), indicating the existence of a dominant petrosal sinus, Endogenous CRH was undetectable in all samples, Despite similar exogenous oCRH levels in both petrosal sinuses, oCRH caused a significant increase (P < 0.001) in the ACTH ISG (15.8+/-5.6, mean+/-SEM), suggesting increased responsiveness of one dominant side of the anterior pituitary. This was associated with an ipsilateral CRH-induced AVP release and a significant increase (P < 0.01) in the AVP ISG (8.6+/-2.3), suggesting lateralized AVP secretion by the hypothalamus. Furthermore, the increased AVP ISG after oCRH correlated strongly with the ACTH ISG (r = 0.92, P < 0.01), oCRH administration did not affect OT, These findings suggest that there is a dominant petrosal sinus in healthy volunteers that appears to reflect a dominant side of the adenohypophysis, characterized by increased functional activity and/or responsiveness of the pituitary corticotrophs. This may reflect lateralized hypothalamic and/or suprahypothalamic function resulting in CRH-responsive lateralized secretion of AVP from parvocellular andlor magnocellular axons in the median eminence and the posterior pituitary. Although the functional and teleologic significance of these findings remains to be investigated, our data suggest a novel mechanism for CRH-mediated ACTH release, namely CRH-induced release of AVP which then enhances CRH action on the corticotrophs. Furthermore, our data represent the first direct evidence for the concept of brain lateralization with respect to neuroendocrine secretion.
引用
收藏
页码:2045 / 2050
页数:6
相关论文
共 54 条
[41]   DIRECTIONAL PITUITARY BLOOD-FLOW - A MICROCINEPHOTOGRAPHIC STUDY [J].
PAGE, RB .
ENDOCRINOLOGY, 1983, 112 (01) :157-165
[42]   THE EFFECT OF OXYTOCIN INFUSION ON ADENOHYPOPHYSEAL FUNCTION IN MAN [J].
PAGE, SR ;
ANG, VTY ;
JACKSON, R ;
WHITE, A ;
NUSSEY, SS ;
JENKINS, JS .
CLINICAL ENDOCRINOLOGY, 1990, 32 (03) :307-313
[43]   COEXISTENCE OF CRF PEPTIDE AND OXYTOCIN MESSENGER-RNA IN THE PARAVENTRICULAR NUCLEUS [J].
PRETEL, S ;
PIEKUT, DT .
PEPTIDES, 1990, 11 (03) :621-624
[44]   VASOPRESSIN RESPONSES TO CORTICOTROPIN RELEASING-FACTOR AND HYPEROSMOLALITY IN CONSCIOUS DOGS [J].
RAFF, H ;
SKELTON, MM ;
MERRILL, DC ;
COWLEY, AW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (06) :R1235-R1239
[45]   MORPHINE INHIBITS THE PITUITARY-ADRENAL RESPONSE TO OVINE CORTICOTROPIN-RELEASING HORMONE IN NORMAL SUBJECTS [J].
RITTMASTER, RS ;
CUTLER, GB ;
SOBEL, DO ;
GOLDSTEIN, DS ;
KOPPELMAN, MCS ;
LORIAUX, DL ;
CHROUSOS, GP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (05) :891-895
[46]   EFFECTS AND PHARMACOKINETIC PROPERTIES OF THE RAT HUMAN CORTICOTROPIN-RELEASING FACTOR IN RHESUS-MONKEYS [J].
SCHURMEYER, TH ;
GOLD, PW ;
GALLUCCI, WT ;
TOMAI, TP ;
CUTLER, GB ;
LORIAUX, DL ;
CHROUSOS, GP .
ENDOCRINOLOGY, 1985, 117 (01) :300-306
[47]   MORPHINE DIRECTLY MODULATES THE RELEASE OF STIMULATED CORTICOTROPHIN-RELEASING FACTOR-41 FROM RAT HYPOTHALAMUS INVITRO [J].
TSAGARAKIS, S ;
NAVARA, P ;
REES, LH ;
BESSER, M ;
GROSSMAN, A .
ENDOCRINOLOGY, 1989, 124 (05) :2330-2335
[48]   EFFECTS OF SYNTHETIC OVINE CORTICOTROPIN-RELEASING FACTOR, GLUCOCORTICOIDS, CATECHOLAMINES, NEUROHYPOPHYSEAL PEPTIDES, AND OTHER SUBSTANCES ON CULTURED CORTICOTROPIC CELLS [J].
VALE, W ;
VAUGHAN, J ;
SMITH, M ;
YAMAMOTO, G ;
RIVIER, J ;
RIVIER, C .
ENDOCRINOLOGY, 1983, 113 (03) :1121-1131
[49]   CHARACTERIZATION OF A 41-RESIDUE OVINE HYPOTHALAMIC PEPTIDE THAT STIMULATES SECRETION OF CORTICOTROPIN AND BETA-ENDORPHIN [J].
VALE, W ;
SPIESS, J ;
RIVIER, C ;
RIVIER, J .
SCIENCE, 1981, 213 (4514) :1394-1397
[50]   VASOPRESSIN COEXISTS IN 1/2 OF THE CORTICOTROPIN-RELEASING FACTOR AXONS PRESENT IN THE EXTERNAL ZONE OF THE MEDIAN-EMINENCE IN NORMAL RATS [J].
WHITNALL, MH ;
SMYTH, D ;
GAINER, H .
NEUROENDOCRINOLOGY, 1987, 45 (05) :420-424